Can perimenopause cause asthma?

Perimenopause does not cause asthma in a woman with no prior airway vulnerability, but it can trigger new-onset asthma in women who were predisposed, and it commonly worsens asthma control in women who already have it. The relationship between female sex hormones and airway function is well established in the research literature, even though it is not always discussed in routine asthma care.

Estrogen and progesterone receptors are present in bronchial smooth muscle and in the epithelial cells lining the airways. This means the airways are directly responsive to hormonal changes. Estrogen's effect on airway function is complex and somewhat paradoxical. At stable physiological levels, estrogen can help regulate inflammatory responses in the airways. But when estrogen fluctuates erratically, as it does throughout perimenopause, it can promote airway inflammation, increase mast cell activity (which drives allergic and inflammatory responses), and heighten bronchial hyperreactivity, meaning the airways become more sensitive and more prone to narrowing in response to triggers such as exercise, cold air, allergens, and irritants.

Progesterone has bronchodilatory effects and drives the respiratory center to breathe more frequently. It also has some anti-inflammatory properties in airway tissue. As progesterone production becomes less consistent during perimenopause, women may lose some of its protective contributions to airway stability.

The perimenstrual pattern is clinically important. Research has consistently shown that asthma attacks, emergency department visits for asthma, and reductions in peak flow measurements cluster in the premenstrual and early menstrual days, when both estrogen and progesterone are at their lowest. This perimenstrual asthma pattern is well recognized. During perimenopause, cycles become irregular and unpredictable, so this hormonal low point can occur at any time rather than at the end of a predictable monthly cycle, making symptoms harder to anticipate and plan around.

Weight gain during perimenopause compounds the problem. Increased abdominal fat reduces lung volume, impairs diaphragm movement, and worsens asthma severity independently of hormonal changes. Gastroesophageal reflux, which also increases during perimenopause due to hormonal effects on the lower esophageal sphincter, is a significant trigger for cough and can worsen asthma control.

Some research has explored whether hormone therapy benefits asthma in perimenopausal women. The data is mixed, with some studies suggesting improvement and others finding no significant effect or even worsening in certain subgroups. This remains an area of ongoing investigation rather than settled science, and decisions about hormone therapy in the context of asthma must be individualized.

Women who had their asthma well controlled for years and notice increased rescue inhaler use, more nighttime symptoms, or more frequent exacerbations during perimenopause should consider whether hormonal changes are contributing, and discuss this with their respiratory physician or GP. Keeping a peak flow diary or using a smart inhaler that logs usage can provide objective data about how asthma control has shifted over time.

Practical asthma management during perimenopause follows the same principles as at any age, with some additional considerations. Ensuring regular use of preventer inhalers (typically inhaled corticosteroids) rather than relying on rescue medication is fundamental. Nasal corticosteroids help manage the upper airway inflammation that often drives lower airway reactivity. Identifying and reducing exposure to personal triggers remains important. Managing reflux, if present, can significantly improve asthma control. Maintaining a healthy weight through regular activity and a balanced diet is a modifiable factor that supports lung function and reduces asthma severity in women with any degree of obesity.

Tracking your symptoms over time, using a tool like PeriPlan, can help you spot patterns between your cycle phase and breathing symptoms, giving you and your doctor useful information about whether hormonal fluctuations are driving your asthma changes.

When to talk to your doctor:

Review your asthma management plan with your doctor if you are using a rescue inhaler more than twice a week, if nighttime symptoms are waking you, or if your asthma has become harder to control during perimenopause. An updated asthma action plan helps you respond appropriately to worsening without delay. Do not adjust doses of asthma medications without medical guidance. Get emergency care immediately for any sudden severe breathing difficulty, inability to complete a full sentence, bluish coloring of lips or fingernails, or an attack that is not responding to your rescue inhaler. Asthma that is worsening significantly and rapidly always requires prompt medical evaluation.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.